Stabilization of Homologous and Heterologous Cell-bound Amplification Convertases, C3bBb, by C3 Nephritic Factor

Overview

Journal Immunology

Specialty Allergy & Immunology

Date 1981 May 1

PMID 6166544

Citations 14

Authors

M R Daha

L A van Es

Affiliations

Soon will be listed here.

Citing Articles

Functional Characterization of Anti-C3bBb Autoantibodies and C3 Glomerulopathy Phenotype.

Roquigny J, Meuleman M, El Sissy C, Cailliez M, Servais A, Roussey G J Am Soc Nephrol. 2024; 36(2):264-273.

PMID: 39325562 PMC: 11801764. DOI: 10.1681/ASN.0000000000000499.

Detection of Complement Factor B Autoantibodies by ELISA.

Jozsi M, Uzonyi B Methods Mol Biol. 2021; 2227:141-145.

PMID: 33847939 DOI: 10.1007/978-1-0716-1016-9_14.

The Immunopathology of Complement Proteins and Innate Immunity in Autoimmune Disease.

Defendi F, Thielens N, Clavarino G, Cesbron J, Dumestre-Perard C Clin Rev Allergy Immunol. 2019; 58(2):229-251.

PMID: 31834594 DOI: 10.1007/s12016-019-08774-5.

C3-Glomerulopathy Autoantibodies Mediate Distinct Effects on Complement C3- and C5-Convertases.

Zhao F, Afonso S, Lindner S, Hartmann A, Loschmann I, Nilsson B Front Immunol. 2019; 10:1030.

PMID: 31214159 PMC: 6554336. DOI: 10.3389/fimmu.2019.01030.

Nephritic Factors: An Overview of Classification, Diagnostic Tools and Clinical Associations.

Corvillo F, Okroj M, Nozal P, Melgosa M, Sanchez-Corral P, Lopez-Trascasa M Front Immunol. 2019; 10:886.

PMID: 31068950 PMC: 6491685. DOI: 10.3389/fimmu.2019.00886.

References

Daha M, van Es L . Activation of the classical pathway of complement by the C3NeF-stabilized cell-bound amplification convertase. J Immunol. 1979; 122(3):801-5. View

Daha M, van Es L . Further evidence for the antibody nature of C3 nephritic factor (C3NeF). J Immunol. 1979; 123(2):755-8. View

Halbwachs L, Leveille M, Lesavre P, Wattel S, Leibowitch J . Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme. J Clin Invest. 1980; 65(6):1249-56. PMC: 371461. DOI: 10.1172/jci109787. View

Daha M, Hazevoet H, Vanes L, Cats A . Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus. Immunology. 1980; 40(3):417-24. PMC: 1458054. View

Daha M, van Es L . Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3. Immunology. 1980; 41(4):849-55. PMC: 1458319. View

Spitzer R, Vallota E, Forristal J, Sudora E, Stitzel A, Davis N . Serum C'3 lytic system in patients with glomerulonephritis. Science. 1969; 164(3878):436-7. DOI: 10.1126/science.164.3878.436. View

Hunsicker L, Ruddy S, Austen K . Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol. 1973; 110(1):128-38. View

Vallota E, Gotze O, Spiegelberg H, Forristal J, WEST C, MULLER-EBERHARD H . A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement. J Exp Med. 1974; 139(5):1249-61. PMC: 2139648. DOI: 10.1084/jem.139.5.1249. View

Thorell J, Larsson I . Lactoperoxidase coupled to polyacrylamide for radio-iodination of proteins to high specific activity. Immunochemistry. 1974; 11(4):203-6. DOI: 10.1016/0019-2791(74)90329-2. View

10.

Fearon D, Austen K . Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. J Exp Med. 1975; 142(4):856-63. PMC: 2189935. DOI: 10.1084/jem.142.4.856. View

11.

Daha M, Fearon D, Austen K . C3 requirements for formation of alternative pathway C5 convertase. J Immunol. 1976; 117(2):630-4. View

12.

Weiler J, Daha M, Austen K, Fearon D . Control of the amplification convertase of complement by the plasma protein beta1H. Proc Natl Acad Sci U S A. 1976; 73(9):3268-72. PMC: 431003. DOI: 10.1073/pnas.73.9.3268. View

13.

Tack B, Prahl J . Third component of human complement: purification from plasma and physicochemical characterization. Biochemistry. 1976; 15(20):4513-21. DOI: 10.1021/bi00665a028. View

14.

Schreiber R, Gotze O, MULLER-EBERHARD H . Nephritic factor: its structure and function and its relationship to initiating factor of the alternative pathway. Scand J Immunol. 1976; 5(6-7):705-13. DOI: 10.1111/j.1365-3083.1976.tb03020.x. View

15.

Daha M, Austen K, Fearon D . The incorporation of C3 nephritic factor (C3NeF) into a stabilized C3 convertase, C3bBb(C3NeF), and its release after decay of convertase function. J Immunol. 1977; 119(3):812-7. View

16.

Daha M, Austen K, Fearon D . Heterogeneity, polypeptide chain composition and antigenic reactivity of C3 nephritic factor. J Immunol. 1978; 120(4):1389-94. View

17.

Scott D, Amos N, Sissons J, LACHMANN P, PETERS D . The immunogloblin nature of nephritic factor (NeF). Clin Exp Immunol. 1978; 32(1):12-24. PMC: 1541306. View